Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2007

01-10-2007 | Article

Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome

Authors: D. Shitrit, R. Priess, N. Peled, G. Bishara, D. Shlomi, M. R. Kramer

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2007

Login to get access

Abstract

This retrospective study sought to systematically identify clinical and radiological features differentiating Mycobacterium kansasii from Mycobacterium tuberculosis infection. The sample included matched patients with a culture-positive diagnosis of M. tuberculosis infection (n = 121) or M. kansasii infection (n = 62) derived from the databases of two tuberculosis centers. Data on patient background and clinical features were collected, and chest radiographs were analyzed. Sixty percent of the M. kansasii group were native Israelis compared to 15% of the M. tuberculosis group (p = 0.0001). M. tuberculosis infection was associated with a higher rate of human immunodeficiency virus (HIV) infection (p = 0.03) and M. kansasii infection with a higher rate of lung disease (p = 0.0001). M. tuberculosis infection was characterized by a higher likelihood of bilateral disease (p = 0.005), pleural effusions, and lymphadenopathy (p = 0.006 and p = 0.001, respectively). There were ten deaths, all in the M. tuberculosis group. On multivariate logistic regression, the presence of chronic obstructive pulmonary disease and associated lung disease were significant predictors of M. kansasii infection. The findings show that there are group differences between the clinical features of the two infections. In the setting of pulmonary mycobacterial infection, the presence of coinfection with HIV, bilateral disease, pleural effusion, and lymphadenopathy make M. kansasii infection very unlikely.
Literature
1.
go back to reference Wolinsky E (1981) When is an infection disease? Rev Infect Dis 3:1025–1027PubMed Wolinsky E (1981) When is an infection disease? Rev Infect Dis 3:1025–1027PubMed
2.
go back to reference Bloch KC, Zwerling L, Pletcher MJ, Hahn JA, Gerberding JL, Ostroff SM, Vugia DJ, Reingold AL (1998) Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 129:698–704PubMed Bloch KC, Zwerling L, Pletcher MJ, Hahn JA, Gerberding JL, Ostroff SM, Vugia DJ, Reingold AL (1998) Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 129:698–704PubMed
3.
go back to reference Wolinsky E (1979) Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119:107–159PubMed Wolinsky E (1979) Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119:107–159PubMed
4.
go back to reference Evans AJ, Crisp AJ, Colville A, Colville A, Evans SA, Johnston ID (1996) Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis. Thorax 51:1243–1247PubMed Evans AJ, Crisp AJ, Colville A, Colville A, Evans SA, Johnston ID (1996) Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis. Thorax 51:1243–1247PubMed
5.
go back to reference Buckner CB, Leithiser R, Waler CW, Allison JW (1991) The changing epidemiology of tuberculosis and other mycobacterial infections in the United States: implications for the radiologist. Am J Radiol 156:255–264 Buckner CB, Leithiser R, Waler CW, Allison JW (1991) The changing epidemiology of tuberculosis and other mycobacterial infections in the United States: implications for the radiologist. Am J Radiol 156:255–264
6.
go back to reference O’Brien RJ, Geiter LJ, Saider DE (1987) The epidemiology of nontuberculous mycobacterial disease in the United States: results from a national survey. Am Rev Respir Dis 135:1007–1014PubMed O’Brien RJ, Geiter LJ, Saider DE (1987) The epidemiology of nontuberculous mycobacterial disease in the United States: results from a national survey. Am Rev Respir Dis 135:1007–1014PubMed
7.
go back to reference Lamden K, Watson JM, Knerer G, Ryan MJ, Jenkins PA (1982) Opportunist mycobacteria in England and Wales: 1982 to 1994. Commun Dis Rep CDR Rev 6:R147–R151 Lamden K, Watson JM, Knerer G, Ryan MJ, Jenkins PA (1982) Opportunist mycobacteria in England and Wales: 1982 to 1994. Commun Dis Rep CDR Rev 6:R147–R151
8.
go back to reference Good RC, Snider DE Jr (1982) Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 146:829–833PubMed Good RC, Snider DE Jr (1982) Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 146:829–833PubMed
9.
go back to reference Griffith DE (2002) Management of disease due to Mycobacterium kansasii. Clin Chest Med 23:613–621PubMedCrossRef Griffith DE (2002) Management of disease due to Mycobacterium kansasii. Clin Chest Med 23:613–621PubMedCrossRef
10.
go back to reference Lillo M, Orengo S, Cernoch P, Harris RL (1990) Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 12:760–767PubMed Lillo M, Orengo S, Cernoch P, Harris RL (1990) Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 12:760–767PubMed
11.
go back to reference Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA (1979) A demographic study of disease due to Mycobacterium kansasii or M. intracellulare-avium in Texas. Chest 75:120–125PubMed Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA (1979) A demographic study of disease due to Mycobacterium kansasii or M. intracellulare-avium in Texas. Chest 75:120–125PubMed
12.
go back to reference Corbett EL, Churchyard GJ, Hay M, Herselman P, Clayton T, Williams B, Hayes R, Mulder D, De Cock KM (1999) The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners. Am J Respir Crit Care Med 160:10–14PubMed Corbett EL, Churchyard GJ, Hay M, Herselman P, Clayton T, Williams B, Hayes R, Mulder D, De Cock KM (1999) The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners. Am J Respir Crit Care Med 160:10–14PubMed
13.
go back to reference Corbett EL, Blumberg L, Churchyard GJ, Moloi N, Mallory K,, Clayton T, Williams BG, Chaisson RE, Hayes RJ, De Cock KM (1999) Nontuberculous mycobacteria defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 160:15–21PubMed Corbett EL, Blumberg L, Churchyard GJ, Moloi N, Mallory K,, Clayton T, Williams BG, Chaisson RE, Hayes RJ, De Cock KM (1999) Nontuberculous mycobacteria defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 160:15–21PubMed
14.
go back to reference Jacobson KL, Teira R, Libshitz HI, Raad I, Rolston KV, Terrand J, Whimbey E (2000) Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis 30:965–969PubMedCrossRef Jacobson KL, Teira R, Libshitz HI, Raad I, Rolston KV, Terrand J, Whimbey E (2000) Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis 30:965–969PubMedCrossRef
15.
go back to reference Evans SA, Colville A, Evans AJ (1996) Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. Thorax 51:1248–1252PubMed Evans SA, Colville A, Evans AJ (1996) Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis. Thorax 51:1248–1252PubMed
16.
go back to reference Wallace RJCJ Jr, Glassroth J, Griffith DE (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156:S1–S25 Wallace RJCJ Jr, Glassroth J, Griffith DE (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156:S1–S25
17.
go back to reference American Thoracic Society (2003) Treatment of tuberculosis. Am J Respir Crit Care Med 167:603–662CrossRef American Thoracic Society (2003) Treatment of tuberculosis. Am J Respir Crit Care Med 167:603–662CrossRef
18.
go back to reference Collins CH, Grange JM, Yates MD (1985) Organization and practice in tuberculous bacteriology. Butterworth, London, pp 619–621 Collins CH, Grange JM, Yates MD (1985) Organization and practice in tuberculous bacteriology. Butterworth, London, pp 619–621
19.
go back to reference Davies PDO (1994) Infection with Mycobacterium kansasii. Thorax 49:435–436PubMed Davies PDO (1994) Infection with Mycobacterium kansasii. Thorax 49:435–436PubMed
20.
go back to reference Maliwan N, Zvertina JR (1985) Pulmonary mycetoma following Mycobacterium kansasii infection. Arch Intern Med 145:180–183CrossRef Maliwan N, Zvertina JR (1985) Pulmonary mycetoma following Mycobacterium kansasii infection. Arch Intern Med 145:180–183CrossRef
21.
go back to reference Chaves AD, Robins AB, Abeles H (1961) Tuberculosis: case finding among homeless men in New York City. Am Rev Respir Dis 84:900–901PubMed Chaves AD, Robins AB, Abeles H (1961) Tuberculosis: case finding among homeless men in New York City. Am Rev Respir Dis 84:900–901PubMed
22.
go back to reference Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP (1983) Pulmonary infection with Mycobacterium kansasii in Wales, 1970–79: review of treatment and response. Thorax 38:271–274PubMedCrossRef Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP (1983) Pulmonary infection with Mycobacterium kansasii in Wales, 1970–79: review of treatment and response. Thorax 38:271–274PubMedCrossRef
23.
go back to reference Christensen EE, Dietz GW (1978) Radiographic manifestations of pulmonary Mycobacterium kansasii infections. Am J Radiol 131:985–993 Christensen EE, Dietz GW (1978) Radiographic manifestations of pulmonary Mycobacterium kansasii infections. Am J Radiol 131:985–993
24.
go back to reference Anderson DH, Grech P, Townshend RH, Jephcot AE (1975) Pulmonary lesions due to opportunist mycobacteria. Clin Radiol 26:461–469PubMedCrossRef Anderson DH, Grech P, Townshend RH, Jephcot AE (1975) Pulmonary lesions due to opportunist mycobacteria. Clin Radiol 26:461–469PubMedCrossRef
25.
go back to reference Zvetina JR, Demos TC (1984) Pulmonary cavitations in Mycobacterium kansasii. Distinction from M. tuberculosis. Am J Radiol 143:127–130 Zvetina JR, Demos TC (1984) Pulmonary cavitations in Mycobacterium kansasii. Distinction from M. tuberculosis. Am J Radiol 143:127–130
26.
go back to reference Horsburgh CR Jr, Selik RM (1989) The epidemiology of disseminated nontuberculous mycobacterial infection in AIDS. Am Rev Respir Dis 139:4–7PubMed Horsburgh CR Jr, Selik RM (1989) The epidemiology of disseminated nontuberculous mycobacterial infection in AIDS. Am Rev Respir Dis 139:4–7PubMed
27.
go back to reference Albelda SM, Kern JA, Marinelli DL (1985) Expanding spectrum of pulmonary disease caused by non-tuberculosis mycobacteria. Radiology 157:289–296PubMed Albelda SM, Kern JA, Marinelli DL (1985) Expanding spectrum of pulmonary disease caused by non-tuberculosis mycobacteria. Radiology 157:289–296PubMed
28.
29.
go back to reference Christensen EE, Dietz GW, Ahn CH, Chapman JS, Murry RC, Anderson J, Hurst GA (1981) Initial roentgenographic manifestations of pulmonary Mycobacterium tuberculosis, M. kansasii and M. intracellularis. Chest 80:132–136PubMed Christensen EE, Dietz GW, Ahn CH, Chapman JS, Murry RC, Anderson J, Hurst GA (1981) Initial roentgenographic manifestations of pulmonary Mycobacterium tuberculosis, M. kansasii and M. intracellularis. Chest 80:132–136PubMed
Metadata
Title
Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome
Authors
D. Shitrit
R. Priess
N. Peled
G. Bishara
D. Shlomi
M. R. Kramer
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2007
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0331-3

Other articles of this Issue 10/2007

European Journal of Clinical Microbiology & Infectious Diseases 10/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.